资讯
- Who We Are
High Purity & QualityEvery batch reaches ≥98% purity, verified by HPLC and mass spectrometry before release.Scalable ProductionFrom R&D samples to bulk commercial supply — consistent quality at any order volume.Fast Global DeliveryIn-stock peptides ship within 1–3 business days. Cus
Our Manufacturing FacilityRadiptide operates a GMP-aligned synthesis and testing facility in Guangzhou. From raw material intake through SPPS synthesis, multi-column HPLC purification, lyophilization and nitrogen-sealed packaging, every step is documented and traceable.We support catalog cosmetic peptides and custom se
- Our Quality Commitment
We understand that raw material quality defines your product reputation. That is why every Radiptide batch goes through rigorous release testing before it leaves our facility.GMP-compliant manufacturing with standardized production workflowsHPLC purity verification on every batchMass spectrome
FDA Approves MIMRYLO (Rusfertide), a Hepcidin-Mimetic Peptide for Polycythemia VeraThe FDA approved rusfertide (MIMRYLO) on August 28, 2026 for polycythemia vera patients needing frequent phlebotomy—marking the first hepcidin-mimetic peptide therapy in the United States.
- FDA Grants Fast Track to PVX108 Peanut Peptide Immunotherapy
PVX108 received FDA Fast Track designation in August 2026 as a synthetic T-cell epitope peptide therapy for peanut allergy—one of the first allergen immunotherapy programs built entirely on short peptides rather than whole extracts.
- ENDO 2026: GLP-1 and Multi-Agonist Peptides Dominate Chicago Readouts
ENDO 2026 in Chicago drew more than 8,000 attendees as GLP-1, dual-agonist, and triple-agonist peptides filled plenary slots, poster halls, and late-breaking abstract sessions.
- Solvent Recovery and Waste-Intensity Metrics Enter Peptide Supplier Scorecards
Peptide suppliers face new scorecard metrics on solvent recovery and waste intensity in 2026.
- Cosmetic Buyers Adopt Research-Grade Release Criteria for Peptide Raw Materials
Cosmetic buyers tighten peptide release criteria; data integrity rises on 2026 audit agendas.
- Peptide Degradation in Multi-Active Skin Care: Mechanisms, Case Studies, and Mitigation Protocols
Technical review of peptide degradation in multi-active formulas and proven mitigation steps.
- Copper Tripeptide GHK-Cu: Market Dynamics, Specification Trends, and Formulation Integration
An analysis of GHK-Cu demand, tightening COA specs, and formulation best practices in 2025.